Predecessor auditor affirms 8-K disclosure
Holt & Patterson confirms it agrees as the predecessor auditor with CTT Pharmaceutical's disclosure in its October 2, 2026 Form 8-K regarding the transition of retained audit files.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed